AFRIVAX GHANA is a pioneering Contract Development and Manufacturing Organization (CDMO) dedicated to developing advanced healthcare solutions for global markets. We combine cutting-edge research with specialized expertise to address complex health challenges worldwide.

Our team of scientists, healthcare professionals, and industry experts work together to create innovative vaccines and therapeutics that are accessible, affordable, and effective for communities around the world, with particular strength in emerging markets.

With state-of-the-art facilities and a commitment to excellence, we're building a healthier future through sustainable, innovative solutions using our proprietary AdCEV®/Egg protein expression system that meets international quality standards.